Cite
CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction.
MLA
Núñez-Marín, Gonzalo, et al. “CA125 Outperforms NT-ProBNP in the Prediction of Maximum Aerobic Capacity in Heart Failure with Preserved Ejection Fraction and Kidney Dysfunction.” Clinical Kidney Journal, vol. 17, no. 8, Aug. 2024, pp. 1–10. EBSCOhost, https://doi.org/10.1093/ckj/sfae199.
APA
Núñez-Marín, G., Palau, P., Domínguez, E., de la Espriella, R., López, L., Flor, C., Marín, P., Lorenzo, M., Miñana, G., Bodí, V., Sanchis, J., & Núñez, J. (2024). CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction. Clinical Kidney Journal, 17(8), 1–10. https://doi.org/10.1093/ckj/sfae199
Chicago
Núñez-Marín, Gonzalo, Patricia Palau, Eloy Domínguez, Rafael de la Espriella, Laura López, Cristina Flor, Paloma Marín, et al. 2024. “CA125 Outperforms NT-ProBNP in the Prediction of Maximum Aerobic Capacity in Heart Failure with Preserved Ejection Fraction and Kidney Dysfunction.” Clinical Kidney Journal 17 (8): 1–10. doi:10.1093/ckj/sfae199.